MedPath

effect of prophylactic Acetaminophen in the prevention PDA (Patent Ductus Arteriosus) in premature neonates

Phase 1
Recruiting
Conditions
Q25.0
Patent ductus arteriosus.
Patent ductus arteriosus
Registration Number
IRCT20081021001378N15
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Consent to participate in the study
Premature babies with a gestational age of less than 30 weeks
Premature infants without evidence of patent ductus arteriosus

Exclusion Criteria

CHF
Liver or kidney disease or cholestasis
congenital heart disease
PPHN
Genetic disorders and congenital malformations
Apgar score 5 minutes less than 5
PH <7.2
Septicemia
Difference in pre-duct and post-duct oxygen saturation is more than 3%

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath